Biliary Tract Cancer Terminated Phase 2 Trials for Bevacizumab (DB00112)

Also known as: Biliary tract cancer / Cancers, Biliary Tract / Malignant neoplasm of biliary tract, unspecified / Malignant tumor of biliary tract / Malignant neoplasm of biliary tract, part unspecified

IndicationStatusPhase
DBCOND0030617 (Biliary Tract Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00881504A Study of FOLFOX6 With Bevacizumab for Biliary System CarcinomaTreatment